Nellson Nutraceutical releases case study on plant-based high-protein segment
Sweegen announced that its Bestevia Rebaudiosides M (Reb M), D, and E have received full authorization from the Taiwan FDA for use in food and beverages. This recent regulatory approval marks another milestone in Sweegen successfully opening new markets in countries where brands seek new generation stevia ingredients, it says. In addition to those critical regulatory approvals, Sweegen now offers its food and beverage manufacturing customers the right to use its Reb M in all non-alcohol beverages anywhere in the world without infringing the relevant application patents. Customers already use Sweegen’s Reb M in other applications. “The approval of Bestevia Reb M in Taiwan represents a breakthrough for brands aiming to create better-for-you foods and beverages,” said Casey McCormick, vice president of global innovation at Sweegen, in a statement. “Bestevia Reb M opens innovative avenues for reducing and even eliminating sugar, surpassing consumer expectations and contributing to public health goals aimed at curtailing sugar intake.” Sweegen also recently achieved FEMA GRAS status for its sweet proteins, brazzein and thaumatin II, which serve as valuable complements to steviol glycosides in the realm of food and beverage production, it adds.